Pre-clinical evaluation of the multitargeted tyrosin kinase inhibitor sunitinib in the treatment of adrenocortical carcinoma (ACC)

  • S Johanssen, M Zink, S Hahner, P Adam, M Fassnacht, B Allolio
  • Experimental and Clinical Endocrinology & Diabetes, January 2007, Thieme Publishing Group
  • DOI: 10.1055/s-2007-972298

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1055/s-2007-972298